GlobeStar Therapeutics Corp (GSTC)
0.0009
0.00 (0.00%)
USD |
OTCM |
May 06, 10:57
GlobeStar Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2019 | -0.1874 |
| September 30, 2019 | -0.166 |
| June 30, 2019 | -0.235 |
| March 31, 2019 | -0.3085 |
| December 31, 2018 | -0.2717 |
| September 30, 2018 | -0.3276 |
| June 30, 2018 | -0.2593 |
| March 31, 2018 | -0.2365 |
| December 31, 2017 | -0.2045 |
| September 30, 2017 | -0.1423 |
| June 30, 2017 | -0.5544 |
| March 31, 2017 | -0.5661 |
| December 31, 2016 | -0.5744 |
| March 31, 2016 | -1.228 |
| Date | Value |
|---|---|
| December 31, 2015 | -2.068 |
| September 30, 2015 | 8.725 |
| June 30, 2015 | -1.200 |
| March 31, 2015 | -1.401 |
| December 31, 2014 | -2.281 |
| September 30, 2014 | -2.457 |
| June 30, 2014 | -3.163 |
| March 31, 2014 | -1.012 |
| December 31, 2013 | -3.739 |
| September 30, 2013 | 0.3109 |
| June 30, 2013 | 0.501 |
| March 31, 2013 | 0.4744 |
| December 31, 2012 | -0.131 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.235
Minimum
Jun 2019
-0.166
Maximum
Sep 2019
-0.1961
Average
-0.1874
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Liabilities (Quarterly) | 1.532M |
| Shareholders Equity (Quarterly) | -1.532M |